IOR – Institute of Oncology Research

Fighting cancer through research

Menu
  • The Institute
    • About
    • Education
    • Staff
    • Jobs
    • Partners
    • Contact
    • Support Us
  • Research
    • Lymphoma and Genomics Research Program
    • Tumor Biology and Experimental Therapeutics Research Program
    • Facilities
      • Bioinformatics Core Unit
      • Genomics Facility
      • Histopathology Facility
      • Preclinical Imaging Facility
  • Groups
    • Cancer Immunotherapy
    • Experimental Hematology
    • Experimental Therapeutics
    • Functional Cancer Genomics
    • Lymphoma Genomics
    • Molecular Oncology
    • Prostate Cancer Biology
  • PhD Program
    • Lecture course 2020-2021
    • Lecture course 2019-2020
    • Lecture course 2018-2019
    • Lecture course 2017-2018
  • Calendar
  • News
  • Scientific Reports

Marco Frigeni, Scientist

Posted on June 21, 2018October 9, 2018 by Isabella Ferrario

Phone: 091 820 0363
Email: marco -dot- frigeni -at- ior -dot- usi -dot- ch

News

IOR study reveals how breast cancer therapy may be effective against COVID-19
17 Feb

IOR study reveals how breast cancer therapy may be effective against COVID-19

The so-called “Selective Estrogen Receptor Modulat...
Technician position
3 Feb

Technician position

The Functional Cancer Genomics group directed by P...
Why Specific Genetic Alterations Matter in Prostate Cancer
2 Feb

Why Specific Genetic Alterations Matter in Prostate Cancer

A given substance may be fundamental for life or m...
View All
Free WordPress Theme | AccessPress Lite
Copyright © 2021 Institute of Oncology Research